CureVac Income Statement (2019-2025) | CVAC

Income Statement Sep2019 Dec2019 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 1.22B-11.71B0.01B0.01B0.01B0.03B0.03B0.05B0.03B0.02B0.01B0.01B0.01B0.01B0.02B0.02B0.01B0.02B0.54B0.02B0.00B0.00B0.06B
Cost of Revenue 0.00B0.03B2.30B0.01B0.02B0.05B0.14B0.08B0.04B0.05B0.02B0.08B0.02B0.03B0.03B0.06B0.05B0.04B0.02B0.00B0.00B0.00B0.00B
Gross Profit 1.22B-11.74B-2.30B-0.00B-0.01B-0.02B-0.10B-0.03B-0.01B-0.02B-0.01B-0.07B-0.01B-0.02B-0.01B-0.03B-0.03B-0.03B0.52B0.01B0.00B-0.00B0.06B
Operating items
Research & Development -0.00B0.05B-0.00B0.23B-0.13B-0.16B-0.06B1.26B-0.01B-0.01B-0.01B0.10B-0.03B-0.03B-0.03B0.21B-0.03B-0.03B-0.05B0.28B-0.04B-0.04B-0.04B
Share-based Compensation (IS) 0.00B9.88B3.84B2.55B-2.42B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Selling, General & Administrative -0.00B0.05B-0.00B0.10B-0.03B-0.04B-0.04B0.21B-0.03B-0.03B-0.03B0.19B-0.02B-0.02B-0.02B0.17B-0.02B-0.02B-0.02B0.13B-0.02B-0.03B-0.03B
Operating Expenses -0.00B0.10B-0.00B0.33B-0.15B-0.19B-0.09B1.47B-0.04B-0.04B-0.04B0.29B-0.05B-0.06B-0.05B0.38B-0.05B-0.05B-0.07B0.41B-0.06B-0.07B-0.07B
Operating Income -21.30B71.20B-0.04B-0.06B-0.14B-0.18B-0.17B-0.01B-0.02B-0.06B-0.05B-0.12B-0.06B-0.08B-0.06B-0.09B-0.08B-0.08B0.40B-0.05B-0.06B-0.07B0.36B
EBIT -21.30B71.20B-0.04B-0.06B-0.14B-0.18B-0.17B-0.01B-0.02B-0.06B-0.05B-0.12B-0.06B-0.08B-0.06B-0.09B-0.08B-0.08B0.40B-0.05B-0.06B-0.07B0.36B
Non-operating items
Interest & Investment Income 0.00B0.00B0.00B-0.00B-0.01B-8.78B-1.81B10.11B0.00B0.00B0.01B-0.01B0.00B0.01B0.01B0.00B-0.00B0.00B0.00B0.02B-0.00B0.00B0.00B
Other Non Operating Income 0.00B-0.00B0.00B-0.00B-0.00B-0.00B-0.00B0.00B-0.00B-0.00B-0.00B-0.00B0.00B-0.00B-0.00B-0.00B
Non Operating Income -0.01B0.00B-0.01B-0.00B0.00B-0.01B0.00B0.01B
Net income details
EBT -0.00B-0.11B-0.04B-0.07B-0.14B-0.18B-0.17B-0.01B-0.02B-0.06B-0.05B-0.13B-0.06B-0.07B-0.05B-0.09B-0.08B-0.08B0.41B-0.04B0.05B-0.07B0.36B
Tax Provisions 0.00B-0.00B-0.00B-0.00B-0.00B0.00B-0.00B0.00B0.00B-0.00B0.00B-0.00B-0.00B-0.00B-0.00B0.00B-0.00B-0.00B-0.04B0.07B-0.00B0.00B-0.04B
Profit After Tax -0.00B-0.11B-0.00B-0.07B-0.14B-0.18B-0.17B-0.00B-0.02B-0.06B-0.05B-0.13B-0.06B-0.07B-0.05B-0.09B-0.08B-0.08B0.37B-0.04B-0.05B-0.07B0.32B
Income from Continuing Operations -0.00B-0.11B-0.04B-0.07B-0.13B-0.18B-0.17B-0.01B-0.02B-0.06B-0.05B-0.13B-0.06B-0.07B-0.05B-0.09B-0.08B-0.08B0.44B-0.11B0.05B-0.07B0.40B
Consolidated Net Income -0.00B-0.11B-0.04B-0.07B-0.13B-0.18B-0.17B-0.01B-0.02B-0.06B-0.05B-0.13B-0.06B-0.07B-0.05B-0.09B-0.08B-0.08B0.44B-0.11B0.05B-0.07B0.40B
Income towards Parent Company -0.00B-0.11B-0.04B-0.07B-0.13B-0.18B-0.17B-0.01B-0.02B-0.06B-0.05B-0.13B-0.06B-0.07B-0.05B-0.09B-0.08B-0.08B0.44B-0.11B0.05B-0.07B0.40B
Net Income towards Common Stockholders -0.00B-0.11B-0.04B-0.07B-0.13B-0.18B-0.17B-0.01B-0.02B-0.06B-0.05B-0.13B-0.06B-0.07B-0.05B-0.09B-0.08B-0.08B0.44B-0.11B0.05B-0.07B0.40B
Additional items
EPS (Basic) -8.57-0.00B-2.54-0.00B-0.00B-0.00B-0.25-0.00B-0.00B-0.00B-5.49-0.00B-0.00B-0.00B-3.23-0.00B-0.00B0.00B-3.780.00B-2.230.00B
EPS (Weighted Average and Diluted) -0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B0.00B0.00B-0.00B0.00B
Shares Outstanding (Weighted Average) 0.01B712.530.03B747.870.00B0.00B0.03B89.79416.15645.300.02B289.80620.69859.990.03B336.77689.210.00B0.03B241.930.03B0.00B
Shares Outstanding (Diluted Average) 747.870.00B0.00B89.79416.15645.30289.80620.69859.99336.77689.210.00B241.93565.980.00B
EBITDA -21.30B71.20B-0.04B-0.06B0.14B0.18B0.17B-0.01B0.02B0.06B0.05B-0.12B0.06B0.07B-0.05B-0.09B0.08B0.08B0.37B-0.05B0.05B0.07B0.32B
Interest Expenses -0.00B0.00B-0.00B0.01B0.00B9.71B-9.52B0.02B-0.00B-0.00B-0.00B0.00B-0.00B-0.00B-0.00B0.00B-0.00B-0.00B-0.00B0.00B0.00B-0.00B-0.01B
Tax Rate -3,388.76%0.59%0.39%4.09%1.31%-0.09%0.36%-23.53%-0.63%0.02%-0.16%0.22%0.00%0.04%0.01%-0.27%0.95%1.83%-8.78%-163.87%-0.83%-0.68%-11.17%